Mostrar el registro sencillo del ítem
Diagnosis of erectile dysfunction can be used to improve screening for Type 2 diabetes mellitus
dc.contributor.author | Carrillo Larco, RM | * |
dc.contributor.author | Luza Dueñas, A.C | * |
dc.contributor.author | Urdániga Hung, M.c | * |
dc.contributor.author | Bernabe-Ortiz, Antonio | es_PE |
dc.date.accessioned | 2018-12-13T22:32:16Z | |
dc.date.available | 2018-12-13T22:32:16Z | |
dc.date.issued | 2018-11 | |
dc.identifier.uri | http://hdl.handle.net/10757/624794 | |
dc.description.abstract | Aims: To assess the diagnostic accuracy of four undiagnosed Type 2 diabetes mellitus risk scores accounting for erectile dysfunction status. Methods: This was a population-based cross-sectional study. Type 2 diabetes was defined according to a oral glucose tolerance test and self-reported physician diagnosis. Erectile dysfunction was defined according to the answer to the question, ‘Have you had difficulties obtaining an erection in the last 6 months?’ (yes/no). The risk scores used were the FINDRISC, LA-FINDRISC, American Diabetes Association score and the Peruvian Risk Score. A Poisson regression model was fitted to assess the association between Type 2 diabetes and erectile dysfunction. The area under the receiver-operating characteristic curve was estimated overall and by erectile dysfunction status. Results: A total of 799 men with a mean (sd) age of 48.6 (10.7) years were included in the study. The overall prevalence of Type 2 diabetes was 9.3%. Compared with healthy men, men with Type 2 diabetes had 2.71 (95% CI 1.57–4.66) higher chances of having erectile dysfunction. Having excluded men aware of Type 2 diabetes status (N=38), the area under the receiver-operating characteristic curve of three of the risk scores (not the American Diabetes Association score) improved among those who had erectile dysfunction in comparison with those who did not; for example, the area under the receiver-operating characteristic curve of the LA-FINDRISC score was 89.6 (95% CI 78.7–99.9) in men with erectile dysfunction and 76.5 (95% CI 68.5–84.4) overall. Conclusions: In a population-based study, erectile dysfunction was more common in men with Type 2 diabetes than in the otherwise healthy men. Screening for erectile dysfunction before screening for Type 2 diabetes seems to improve the accuracy of well-known risk scores for undiagnosed Type 2 diabetes. | en_US |
dc.description.sponsorship | Antonio Bernabe-Ortiz is a Research Training Fellow in Public Health and Tropical Medicine (103994/Z/14/Z), funded by the Wellcome Trust. | en_US |
dc.format | application/pdf | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.rights | Attribution-NonCommercial-ShareAlike 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/us/ | * |
dc.source | Universidad Peruana de Ciencias Aplicadas (UPC) | es_PE |
dc.source | Repositorio Academico - UPC | es_PE |
dc.title | Diagnosis of erectile dysfunction can be used to improve screening for Type 2 diabetes mellitus | en_US |
dc.type | info:eu-repo/semantics/article | en_US |
dc.identifier.journal | Diabetic Medicine | en_US |
dc.description.peerreview | Revisión por pares | es_PE |
dc.identifier.isni | 0000 0001 2196 144X |
Este ítem aparece en la(s) siguiente(s) colección(ones)
-
Medicina [970]